toggle visibility Search & Display Options

Select All    Deselect All
 |   | 
Details
   print

Deprecated: preg_replace(): The /e modifier is deprecated, use preg_replace_callback instead in /home/acutrialsocom/public_html/refbase-ocom/includes/include.inc.php on line 5275
  Record Links
Author (up) Vas, J.; Aranda-Regules, J. M.; Modesto, M.; Ramos-Monserrat, M.; Baron, M.; Aguilar, I.; Benitez-Parejo, N.; Ramirez-Carmona, C.; Rivas-Ruiz, F. url  doi
openurl 
  Title Using moxibustion in primary healthcare to correct non-vertex presentation: a multicentre randomised controlled trial Type of Study RCT
  Year 2013 Publication Acupuncture in medicine : journal of the British Medical Acupuncture Society Abbreviated Journal Acupunct Med  
  Volume 31 Issue 1 Pages 31-38  
  Keywords AcuTrials; RCT; Labor, Obstetric; Breech Presentation; Moxibustion; Acu + Usual Care Versus > 1 Control; TCM Acupuncture Style; Fixed Acupuncture Protocol; Restricted Modalities, Acupuncture Only; Sham Control; Non Specific Acupoint Control; Usual Care Control, Multimodality  
  Abstract OBJECTIVE: To compare the effectiveness of additional moxibustion at point BL67 with moxibustion at a non-specific acupuncture point and with usual care alone to correct non-vertex presentation. METHODS: This was a multicentre randomised controlled trial in which 406 low-risk pregnant women with a fetus in ultrasound breech presentation, with a gestational age of 33-35 weeks, were assigned to (1) true moxibustion at point BL67 plus usual care; (2) moxibustion at SP1, a non-specific acupuncture point (sham moxibustion) plus usual care; or (3) usual care alone. The primary outcome was cephalic presentation at birth. Women were recruited at health centres in primary healthcare. RESULTS: In the true moxibustion group, 58.1% of the full-term presentations were cephalic compared with 43.4% in the sham moxibustion group (RR 1.34, 95% CI 1.05 to 1.70) and 44.8% of those in the usual care group (RR 1.29, 95% CI 1.02 to 1.64). The reduction in RR of the primary outcome in women allocated to the true moxibustion group compared with the usual care group was 29.7% (95% CI 3.1% to 55.2%) and the number needed to treat was 8 (95% CI 4 to 72). There were no severe adverse effects during the treatment. CONCLUSIONS: Moxibustion at acupuncture point BL67 is effective and safe to correct non-vertex presentation when used between 33 and 35 weeks of gestation. We believe that moxibustion represents a treatment option that should be considered to achieve version of the non-vertex fetus. TRIAL REGISTRATION: Current Controlled Trials ISRCTN10634508.  
  Address Pain Treatment Unit, Dona Mercedes Primary Health Care Centre, Andalusian Public Health System, Dos Hermanas, Sevilla 41700, Spain. jorgef.vas.sspa@juntadeandalucia.es  
  Publisher
  Language Number of Treatments 14  
  Treatment Follow-up 3 Weeks Frequency >1/WK Number of Participants 406  
  Time in Treatment 2 Weeks Condition Breech Presentation
  Disease Category Labor, Obstetric OCSI Score  
  Notes Approved no  
  Call Number Serial 1200  
Permanent link to this record
Select All    Deselect All
 |   | 
Details
   print

Save Citations:
Export Records: